Isatuximab in combination for untreated multiple myeloma when a stem cell transplant is unsuitable
Technology appraisal guidance
Reference number: TA1098
Published:
Unfortunately, due to unforeseen capacity constraints during the critique phase of this appraisal, the timelines for this topic have been adjusted. This means the committee meeting will be moving from April 2025 to May 2025.